Font Size
A
A
A

Prostaglandins and Prostaglandin Inhibitors for Congenital Heart Defects


Prostaglandins and Prostaglandin Inhibitors for Congenital Heart Defects

Normally, a blood vessel needed only for fetal blood circulationClick here to see an illustration. (called the ductus arteriosus) closes off at birth. During fetal development, this blood vessel is kept open by a naturally occurring substance in the fetus's body called prostaglandin. At birth, fetal production of prostaglandin decreases and the ductus arteriosus closes.

In some premature infants, this blood vessel does not close. This is a condition called a patent (open) ductus arteriosus. These premature infants are given a prostaglandin inhibitor, a medicine to stimulate the closure of this blood vessel.

When an infant has certain other congenital heart defects, a medicine (a form of prostaglandin) is often given by vein to keep the ductus arteriosus open. Keeping this blood vessel open allows the blood to continue circulating until surgery or another procedure can be done to correct the related defect and allow normal blood flow.

Credits

ByHealthwise Staff
Primary Medical ReviewerJohn Pope, MD - Pediatrics
Specialist Medical ReviewerLarry A. Latson, MD - Pediatric Cardiology
Last RevisedOctober 11, 2011

eMedicineHealth Medical Reference from Healthwise

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.






Medical Dictionary